Related Experiment Video
Updated: Feb 6, 2026

Microfluidic Device for Recreating a Tumor Microenvironment in Vitro
Published on: November 20, 2011
Role of mTOR Signaling in Tumor Microenvironment: An Overview
Fabiana Conciatori1, Chiara Bazzichetto2,3, Italia Falcone4
1Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Rome 00144, Italy. fabiana.conciatori@ifo.gov.it.
Abstract:
The mammalian target of rapamycin (mTOR) pathway regulates major processes by integrating a variety of exogenous cues, including diverse environmental inputs in the tumor microenvironment (TME). In recent years, it has been well recognized that cancer cells co-exist and co-evolve with their TME, which is often involved in drug resistance. The mTOR pathway modulates the interactions between the stroma and the tumor, thereby affecting both the tumor immunity and angiogenesis. The activation of mTOR signaling is associated with these pro-oncogenic cellular processes, making mTOR a promising target for new combination therapies. This review highlights the role of mTOR signaling in the characterization and the activity of the TME's elements and their implications in cancer immunotherapy.
Insights
The mammalian target of rapamycin (mTOR) pathway integrates environmental cues within the tumor microenvironment (TME). Understanding mTOR
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- The tumor microenvironment (TME) significantly influences cancer progression and drug resistance.
- Cancer cells and the TME are intricately linked, co-existing and co-evolving.
- The mammalian target of rapamycin (mTOR) pathway is a critical regulator of cellular processes influenced by external signals.
Purpose of the Study:
- To review the role of the mTOR pathway in shaping the TME.
- To explore how mTOR signaling affects tumor immunity and angiogenesis.
- To highlight mTOR as a potential target for novel combination cancer therapies.
Main Methods:
- Literature review focusing on mTOR signaling in the context of the TME.
- Analysis of studies investigating the interplay between mTOR, TME components, and cancer progression.
- Synthesis of information on mTOR's impact on tumor immunity and angiogenesis.
Main Results:
- mTOR pathway activation is associated with pro-oncogenic processes within the TME.
- mTOR signaling modulates interactions between tumor stroma and cancer cells.
- The pathway influences key aspects of the TME, including immune cell activity and blood vessel formation.
Conclusions:
- The mTOR pathway plays a crucial role in characterizing the TME's composition and activity.
- Targeting mTOR signaling holds promise for improving cancer immunotherapy outcomes.
- Further research into mTOR-based combination therapies is warranted.
More Related Videos
08:32Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
Published on: June 7, 2018
05:44Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
Published on: November 5, 2020
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Tumor Microenvironment
PI3K/mTOR/AKT Signaling Pathway
Overview of Cell Signaling
Cells respond to many types of information, often through receptor proteins positioned on the membrane. For example, skin cells respond to and transmit touch...
Signal Transduction: Overview
Typically, signal transduction involves three...
¹H NMR Signal Integration: Overview